Back to Results
First PageMeta Content
Stem cells / Biotechnology / Emerging technologies / Personalized medicine / University of Ottawa Heart Institute / Induced pluripotent stem cell / Genetic testing / Cardiovascular disease / Pharmacogenomics / Biology / Genomics / Pharmacology


Scientific Organizers: Ruth McPherson (Chair), Katey Rayner (Co-Chair), Peter Liu, xxxx
Add to Reading List

Document Date: 2014-07-18 10:18:01


Open Document

File Size: 171,69 KB

Share Result on Facebook

Company

Canadian Agency for Drugs / 4th Annual Canadian Cardiac Oncology Network / /

Event

Product Recall / Product Issues / /

Facility

Ottawa Heart Institute / Dr Naveen Pereira Mayo Clinic / Dr Thomas Force Temple University / Break Dr Robert Roberts University of Ottawa Heart Institute Colonel By Foyer JOINT PLENARY SESSION / Hospital Colonel By Foyer SESSION III New Kids / Dr William Stanford Ottawa Hospital Research Institute / Dr Pei Pei Ping University of California / /

IndustryTerm

technology assessment frameworks / /

MedicalCondition

blood vessel disease / cancer / disease / atherosclerosis / Cardiovascular Disease / heart failure / cardiac disease / Coronary Artery Disease / /

Organization

Dr Philip Marsden St Michael’s Hospital / Temple University / Technologies in Health / Difference Dr Brian O’Rourke Canadian Agency for Drugs and Technologies / University of California / Los Angeles / Dr William Stanford Ottawa Hospital Research Institute / University of Ottawa Heart Institute / Better Dr Ruth McPherson University of Ottawa Heart Institute Understanding of Complex Disease / /

Person

Ruth McPherson / Chaim Birnboim / Katey Rayner / Philip Marsden St Michael / Paul Lem Spartan / Thierry Mesana / /

Position

Colonel / President and CEO / Vice Chair / Chair / /

Product

drug response * / Clopidogrel / drug effect * / /

ProvinceOrState

California / /

Technology

Stem Cells / /

SocialTag